About Us

ObelysQ was founded in 2020 in Neuchâtel, Switzerland, by former Celgene colleagues and long-time friends Ludovic Moulin and Arnaud Levain Chavanon, driven by a shared vision: to promote quality assurance within the pharmaceutical and biotech industries.

Since its creation, ObelysQ has grown into a leading global clinical quality consulting company, recognized for its expertise in GxP auditing, inspection readiness, quality management system development, training, and data privacy services.

Our experts combine deep regulatory knowledge with hands-on operational insight to deliver pragmatic, risk-based, and tailored solutions that strengthen compliance and clinical executions.

We proudly support biotechnology companies, pharmaceutical organizations, service providers, and clinical research sites worldwide in achieving sustainable quality excellence.

Values

We hold ourselves to the highest standards of integrity and transparency

Ethics comes First

Clinical trials subjects’ well-being, safety and rights as well as the reliability of the data dictate our actions and decisions.

We go the extra mile

We strive to go above and beyond customers’ needs and expectations by being proactive and addressing their requests diligently and efficiently.

We deliver the highest added value

We provide our customers with solutions that are tailored to their needs and means. Our deliverables are impactful.

Why the name ObelysQ ?

From an early stage in mankind’s history, humans have had this urge to leave their mark, commemorate important events, and share their beliefs. Obelisks were firstly erected by Egyptians, but the shape was then also reused in the Roman and Byzantine Empires. Nowadays, we can find obelisks around the globe and the term Obelisk is also present in many languages. We believe that the strong imagery of the obelisk fits perfectly with the values of the company that we are creating. Owners strive to leave their mark in the realm of clinical trials by providing solid GCP solutions.

Team

Working together

Board members

Arnaud Levain Chavanon

Managing Director

Arnaud is Pharm D. and holds a Master's Degree in Quality Assurance. He has lived in several countries (France, United Kingdom, Belgium, and Switzerland) and has been in the GCP environment for over 20 years working for major pharma companies such as Novartis, Bayer, Wyeth, UCB and Celgene.

Ludovic Moulin

Managing Director

Ludovic has worked in the field of Quality Assurance for over 15 years. First starting in the GMP/GLP area in a Pharmaceutical Microbiology lab, he then moved to GCP to broaden his knowledge quality assurance principles. After working for five years in Canada, he relocated to Switzerland to join the Clinical Quality Assurance department of Celgene where he became an Associate Director and Program Lead.

Nicolas Perrigault

Board Member

Nicolas Perrigault is a seasoned Swiss attorney-at-law and certified Swiss tax expert with over 25 years of experience in Swiss and international taxation. He has advised a wide range of clients — from startups and SMEs to large multinational corporations — on corporate and personal tax strategy, transaction tax planning, VAT and indirect taxes, tax disputes, due diligence and cross-border structuring. Nicolas also serves as Of Counsel at a reputable Swiss law firm, where he provides pragmatic, actionable legal and tax solutions. Beyond his legal practice, he holds board positions in several companies, contributes his expertise to operational and fiduciary firms, and serves as an Associate Judge on the State of Vaud Tax Court. He holds degrees in Swiss and European law and is active in professional tax and legal associations.

Management team

Maria Sliwowska

Head of pharmacovigilance and data protection services

Maria is a physician by education, holds a degree in epidemiology, and is currently certified as Information Privacy Professional/Europe (CIPP/E). For the past 20 years, she has worked in various Quality Assurance roles across GCP, GCLP, GVP, CSV and data privacy and advanced analytics space.

Petra Sicher

Head of GCP audits and inspections

Petra is a physician by education and worked in geriatrics, neuro-rehabilitation, palliative care, psychiatry and psycho-oncology. 15 years ago she changed to clinical research, first as Medical Reviewer before switching to Quality Assurance. Petra she has conducted over 200 GCP audits, led multiple inspection readiness activities as well as compliance training activities.

Erin Conlin

Managing Director Americas

Erin Conlin is an accomplished clinical operations professional with over 25 years of comprehensive experience in the pharmaceutical and biotech industries. Holding a Master in Drug Regulatory Affairs and Health Policy with experience as an FDA investigator, she has a unique and deep understanding of the role quality plays in drug development. Erin leads the US office supporting ObelysQ’s expansion into the Americas.

Across the Globe

Our offices